期刊文献+

应用液相芯片技术对上海地区尖锐湿疣患者进行人乳头瘤病毒分型 被引量:1

Liquid chips in genotyping of human papillomavirus in patients with condyloma acuminata in Shanghai
下载PDF
导出
摘要 目的采用液相芯片技术分析上海地区尖锐湿疣患者人乳头瘤病毒(HPV)型别的分布情况。方法从116例尖锐湿疣患者的疣体标本中提取脱氧核糖核酸(DNA),应用液相芯片技术进行HPV基因型检测,并与聚合酶链反应(PCR)的检测结果进行比较,明确液相芯片的检测效能。结果液相芯片检测的116例标本中,HPV阳性114例,阳性率为98.3%。其中单一型别感染占71.6%(83/116),双重型别感染占18.1%(21/116),三重型别感染占7.8%(9/116),四重型别感染占0.9%(1/116)。共检出18种HPV亚型,其中HPV6和HPV11最为常见,感染率分别为60.3%(70/116)和42.2%(49/116)。在高危型HPV感染中,最常见的3种亚型依次为HPV16、HPV52和HPV18。液相芯片与PCR检测结果的符合率为90.7%,并且液相芯片对多重感染的检出率高于PCR。结论上海地区尖锐湿疣以HPV6和HPV11感染为主。高危型HPV感染中最常见的3种亚型依次为HPV16、HPV52和HPV18。液相芯片对HPV多重感染的检出率高于PCR。 Objective To use liquid chips (luminex method) for investigating the distribution of human papillomavirus (HPV) genotypes in patients with condyloma acuminata in Shanghai. Methods The biopsy specimens were obtained from 116 patients with condyloma acuminate and the deoxyribonucleic acids were extracted for analysis using liquid chips; the results were compared with those obtained by type-specific polymerase chain reaction (PCR) so as to assess the efficacy of liquid chips. Results Liquid chips showed that 114 of the 116 specimens were HPV positive, with the positive rate being 98.3%, including 71.6% (83/116) with single infection, 18.1% (21/116) with double infection, 7.8% (9/116) with triple infection and 0.9% (1/116) with quadruple infection. Eighteen genotypes were identified by liquid chips, among which HPV 6 and HPV 11 were the two most common types, with infection rates being 60.3% (70/116) and 42.2% (49/116), respectively. The top three high-risk HPV genetypes were HPV16, HPV52 and HPV18. The consistent rate between liquid chips and PCR for HPV genotyping was 90.7%. Besides, liquid chip had a high sensitivity than PCR for detection of multiple infection. Conclusion HPV6 and HPV11 are the 2 major HPV genotypes in patients with condyloma acuminata in Shanghai. The top three high-risk HPV genotypes are HPV16, HPV52 and HPV18 in order. The liquid chips have a higher sensitivity than PCR for dectection of HPV. (Shanghai Med J, 2009, 32, 892-895)
出处 《上海医学》 CAS CSCD 北大核心 2009年第10期892-895,共4页 Shanghai Medical Journal
基金 上海市卫生局科技发展基金资助项目(054015)
关键词 尖锐湿疣 人乳头瘤病毒 液相芯片 Condyloma acuminata Human papillomavirus Liquid chip
  • 相关文献

参考文献20

  • 1Munoz N,Bosch F X,de Sanjosé S,et al.Epidemiologic classification of human papillomavirus types associated with cervical cancer.N Engl J Med,2003,348:518-527.
  • 2Bardin A,Vaccarella S,Clifford G M,et al.Human papillomavirus infection in women with and without cervical cancer in Warsaw,Poland.Eur J Cancer,2008,44:557-564.
  • 3Tachezy R,Jirasek T,Salakova M,et al.Human papillomavirus infection and tumours of the anal canal:correlation of histology,PCR detection in paraffin seetions and serology.APMIS,2007,115:195-203.
  • 4Van Doornum G J,Korse C M,Buning-Kager J C,et al.Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites.Br J Cancer,2003,88:1095-1100.
  • 5De Franeesco M A,Gargiulo F,Schreiber C,et al.Detection and genotyping of human papillomavirus in cervical samples from Italian patients.J Med Virol,2005,75:588-592.
  • 6Yaoi T,Jiang X,Li X.Development of a fluorescent microsphere-based multiplexed high-throughput assay system for profiling of transcription factor activation.Assay Drug Dev Technol,2006,4:285-292.
  • 7Kellar K L,Iannone M A.Multiplexed microsphere-based flow cytometric assays.Exp Hematol,2002,30:1227-1237.
  • 8Nolan J P,Mandy F F.Suspension array technology:new tools for gene and protein analysis.Cell Mol Biol (Noisy-legrand),2001,47:1241-1256.
  • 9Nolan J P,Sklar L A.Suspension array technology:evolution of the flat-array paradigm.Trends Biotechnol,2002,20:9-12.
  • 10Orlandi A,Francesconi A,Angeloni C,et al.Prevalence and genotyping of human papillomavirus infection in women with vulvodynia.Acta Obstet Gynecol Scand,2007,86:1003-1010.

二级参考文献11

  • 1Koutsky L. Epidemiology of genital human papillomavirus infection.Am J Med, 1997, 102: 3-8.
  • 2zur Hausen H. Roots and perspectives of contemporary papillomavirus research. J Cancer Res Clin Oncol, 1996, 122: 3-13.
  • 3No authors listed. Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. MMWR Recomm Rep, 1997, 46: 1-55.
  • 4Leonard CL, Zhu WY, Kinsey WH, et al. Trichilemmol/Lomas are not associated with human papillomavirus DNA. J Cutan Pathol, 1990,18: 193-197.
  • 5Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol, 2000, 38: 357-361.
  • 6van den Brule AJ, Claas EC, du Maine M, et al. Use of anticontamination primers in the polymerase chain reaction for the detection of human papilloma virus genotypes in cervical scrapes and biopsies. J Med Virol, 1989, 29: 20-27.
  • 7Walboomers JM,Jacobs MV,Manos MM.Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[J].J Pathol,1999,189(1):12-19.
  • 8Dell G,Gaston K.Human papillomaviruses and their role in cervical cancer[J].Cell Mol Life Sci,2001,58(12-13):1923-1942.
  • 9Schmitt M,Bravo IG,Snijders PJ,et al.Bead-based multiplex genotyping of human papillomaviruses[J].J Clin Microbiol,2006,44(2):504-512.
  • 10Jiang HL,Zhu HH,Zhou LF,et al.Genotyping of human papillomavirus in cervical lesions by L1 consensus PCR and the Luminex xMAP system[J].J Med Microbiol,2006,55(Pt 6):715-720.

共引文献45

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部